ArticleJACC. Case reports2026
Extensive Cardiac Involvement in ANCA-Associated Vasculitis Presenting With Severe Aortic Regurgitation and Atrioventricular Block.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntineutrophil cytoplasmic antibody (ANCA)-associated vasculitis rarely presents with severe inflammatory cardiac involvement. Valvuloaortic disease with high-grade atrioventricular block is particularly uncommon. CASE SUMMARY: A 53-year-old woman was referred with a presumptive diagnosis of non-ST-segment elevation myocardial infarction. Coronary angiography showed no obstructive epicardial coronary artery disease. Multimodality imaging demonstrated severe aortic regurgitation, inflammatory valvuloaortic thickening with cusp retraction, moderate pericardial effusion, nonischemic septal late gadolinium enhancement, and progressive high-grade atrioventricular block. Rheumatologic assessment supported myeloperoxidase-positive ANCA-associated vasculitis. She underwent mechanical aortic valve replacement and cardiac resynchronization therapy pacemaker implantation. Rituximab was subsequently initiated as immunosuppressive therapy. Histopathology showed active inflammatory valvulitis without detectable microorganisms. DISCUSSION: This case highlights a rare but clinically important inflammatory cardiac phenotype and underscores the value of multimodality imaging and multidisciplinary evaluation. TAKE-HOME MESSAGE: ANCA-associated vasculitis may rarely present as multicompartment cardiac involvement and should be considered in severe inflammatory valvuloaortic disease with conduction abnormalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.